Collgard Biopharmaceuticals
This article was originally published in Start Up
Executive Summary
The founders of Collgard sought to find biochemical responses common to many different diseases, in order to develop a technology platform with many applications. Collgard believes it has found such a link, in the excess deposition of the protein collagen type 1 that occurs in response to tissue trauma.